Skip to Main Content

Advertisement

Skip Nav Destination

Abstract A44: 18F-FLT, a potential biomarker for predicting the synergistic combination of PI3K inhibitor BAY 80-6946* and MEK inhibitor BAY 86-9766.

Mol Cancer Ther (2011) 10 (11_Supplement): A44.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal